References
Acheson ED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. American Journal of Medicine 26: 569–595, 1959
Adolphe AB. Chronic fatigue syndrome: possible effective treatment with nifedipine. American Journal of Medicine 85: 892, 1988
Anderson JA, Chai H, Claman HV. Candidiasis hypersensitivity syndrome. Journal of Allergy and Clinical Immunology 78: 271–273, 1986
Andersson J, Britton S, Ernberg I, Andersson U, Henle W, et al. Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study. Journal of Infectious Diseases 153: 283–290, 1986
Andersson J, Ernberg I. Management of Epstein-Barr virus infections. American Journal of Medicine 85 (Suppl. 2A): 107–115, 1988
Beard G. Neurasthenia or nervous exhaustion. Boston Medical and Surgical Journal 3 (new series): 217–220, 1869
Behan PO, Behan WMH. Postviral fatigue syndrome. CRC Critical Reviews in Neurobiology 4: 157–178, 1988
Behan PO, Behan WMH, Bell EJ. The postviral fatigue syndrome: an analysis of the findings in 50 cases. Journal of Infection 10: 211–222, 1985
Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, et al. A comparison of cyclobenzaprine and placebo in the management of fibrositis: a double-blind controlled study. Arthritis and Rheumatism 31: 1535–1542, 1988
Buchwald D, Goldenberg DL, Sullivan JL, Komaroff AL. The ‘chronic active Epstein-Barr virus infection’ syndrome and primary fibromyalgia. Arthritis and Rheumatism 30: 1132–1136, 1987
Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. Journal of Immunology 139: 3306–3313, 1987
Dale JK, Straus SE, Ablashi DV, Salahuddin ZS, Gallo RC, et al. The Inoue-Melnick virus, human herpesvirus type 6, and the chronic fatigue syndrome. Annals of Internal Medicine 110: 92–93, 1989
Dillon MJ, Marshall WC, Dudgeon JA, Steigman AJ. Epidemic neuromyasthenia: outbreak among nurses at a children’s hospital. British Medical Journal 1: 301–305, 1974
DuBois RE. Gamma globulin therapy for chronic mononucleosis syndrome. AIDS Research 2: S191–S195, 1986
DuBois RE, Seeley J, Brus I, Sakamoto K, Ballow M, et al. Chronic mononucleosis syndrome. Southern Medical Journal 77: 1376–1382, 1984
Galpine JF, Brady C. Benign myalgic encephalomyelitis. Lancet 1: 757, 1957
Gilliam AG. Epidemiologic study of epidemic diagnosed as poliomyelitis, occurring among personnel of Los Angeles County General Hospital during the summer of 1934. US Public Health Service, Division of Infectious Diseases, Institute of Health, Bulletin 240, pp. 1–90, 1938
Glaser R, Kiecolt-Glaser K. Stress-associated depression in cellular immunity: implications for acquired immune deficiency syndrome (AIDS). Brain, Behavior and Immunity 1: 107–112, 1987
Goldenberg DL, Felson DT, Dinerman H. A randomized controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis and Rheumatism 29: 1371–1377, 1986
Goldstein JA. Cimetidine, ranitidine and Epstein-Barr virus infection. Annals of Internal Medicine 105: 139, 1986
Henderson DA, Shelokov A. Epidemic neuromyasthenia: clinical syndrome? New England Journal of Medicine 260: 757–764; 814–818, 1959
Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, et al. Chronic fatigue syndrome: a working case definition. Annals of Internal Medicine 108: 387–389, 1988
Jones JF, Ray CG, Minnich LL, Hicks J, Kibler R, et al. Evidence for active Epstein-Barr virus infection in patients with persistent unexplained illness: elevated anti-early antigen antibodies. Annals of Internal Medicine 102: 1–7, 1985
Jones JF, Straus SE. Chronic Epstein-Barr virus infection. Annual Review of Medicine 38: 195–209, 1987
Komaroff AL, Geiger AM, Wormsely S. IgG subclass deficiencies in chronic fatigue syndrome. Lancet 1: 1288–1289, 1988
Komaroff AL, Straus SE, Gantz NM, Jones JF. The chronic fatigue syndrome. Annals of Internal Medicine 110: 407–408, 1989
Kruesi MJP, Dale JK, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. Journal of Clinical Psychiatry 50: 53–56, 1989
McEvedy CP, Beard AW. Royal Free epidemic of 1955: a reconsideration. British Medical Journal 1: 7–11, 1970
Medical Staff of the Royal Free Hospital. An outbreak of encephalomyelitis in the Royal Free Hospital Group, London, in 1955. British Medical Journal 2: 895–904, 1957
Meth RJ. Chronic fatigue. Correspondence. Journal of the American Medical Association 261: 696–697, 1989
Pagano JS, Sixbey JW, Lin J-C. Acyclovir and Epstein-Barr virus infection. Journal of Antimicrobial Chemotherapy 12: B113–B121, 1983
Poskanzer DC, Henderson DA, Kunkle EC, Kalter SS, Clement WB, et al. Epidemic neuromyasthenia: an outbreak in Punta Gorda, Florida. New England Journal of Medicine 257: 356, 1957
Quinn JP, Venezio FR. Ketoconazole and the yeast connection. Journal of the American Medical Association 255: 3250, 1986
Rabkin J, Quitkin F, Harrison W, Tricamo E, McGrath P. Adverse reactions to monoamine oxidase inhibitors. Part I: a comparative study. Journal of Clinical Psychopharmacology 4: 270–278, 1984
Rabkin J, Quitkin FM, McGrath P, Harrison W, Tricamo E. Adverse reactions to monoamine oxidase inhibitors. Part II: treatment correlates and clinical management. Journal of Clinical Psychopharmacology 5: 2–9, 1985
Read R, Spickett G, Harvey J, Edwards AJ, Larson HE. IgGl subclass deficiency in patients with the chronic fatigue syndrome. Correspondence. Lancet 1: 241–242, 1988
Renfro L, Feder HM, Lane TJ, Manu P, Matthews DA. Yeast connection among 100 patients with chronic fatigue. American Journal of Medicine 86: 165–168, 1989
Rosenberg GA, Appenzeller O. Amantadine, fatigue and multiple sclerosis. Archives of Neurology 45: 1104–1106, 1988
Shelokov A, Habel K, Verder E, et al. Epidemic neuromyasthenia: an outbreak of poliomyelitis-like illness in student nurses. New England Journal of Medicine 257: 345–355, 1957
Sigurdsson B, Gudmundsson KR. Clinical findings six years after outbreak of Akureyri disease. Lancet 1: 766–767, 1956
Sigurdsson B, Sigurjonsson J, Sigurdsson JH, Thorkelsson J, Gudmundsson KR. A disease epidemic in Iceland simulating poliomyelitis. American Journal of Hygiene 52: 222–238, 1950
Straus SE. The chronic mononucleosis syndrome. Journal of Infectious Diseases 157: 405–412, 1988
Straus SE, Dale JK, Tobi M, Lawley T, Preble O, et al. Acyclovir treatment of the chronic fatigue syndrome: lack of efficacy in a placebo-controlled trial. New England Journal of Medicine 319: 1692–1698, 1988a
Straus SE, Dale JK, Wright R, Metcalfe DD. Allergy and the chronic fatigue syndrome. Journal of Allergy and Clinical Immunology 81: 791–795, 1988b
Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Annals of Internal Medicine 102: 7–16, 1985
Taerk GS, Toner BB, Salit IE, Garfinkel PE, Ozersky S. Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis). International Journal of Psychiatry in Medicine 17:49–56, 1987
Tobi M, Morag A, Ravid Z, Chowers I, Feldman-Weiss V, et al. Prolonged atypical illness associated with serologic evidence of persistent Epstein-Barr virus infection. Lancet 1: 61–64, 1982
Tollefson GD. Monoamine oxidase inhibitors: a review. Journal of Clinical Psychiatry 44: 280–288, 1983
Tucker GJ. Psychiatric disorders in medical practice. In Wyngaarden JB & Smith Jr LH (Eds) Cecil textbook of medicine, 18th ed., pp. 2091–2100, WB Saunders Company, Philadelphia, 1988
White DN, Burtch RB. Iceland disease: new infection simulating acute anterior poliomyelitis. Neurology 4: 506–516, 1954
Yousef GE, Bell EJ, Mann GP, Murugesan V, Smith DG, et al. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet 1: 146–150, 1988
Zimmerman MH, Weber E. Candida and ‘20th Century disease’. Canadian Medical Association Journal 133: 965–966, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gantz, N.M., Holmes, G.P. Treatment of Patients with Chronic Fatigue Syndrome. Drugs 38, 855–862 (1989). https://doi.org/10.2165/00003495-198938060-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198938060-00003